Operating income increased 98.7%
Operating income changed +98.7% from the comparable as-filed period.
$60.7M→$120.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CRDO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy increased 61.5%
Free-cash-flow proxy changed +61.5% from the comparable as-filed period.
$51.3M→$82.9M2 prior comparisons
Operating cash flow increased 66.6%
Operating cash flow changed +66.6% from the comparable as-filed period.
$54.2M→$90.2M2 prior comparisons
Gross margin moved 288 bp lower
Gross margin changed -288 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
67.41%→64.53%2 prior comparisons
Net income increased 104.1%
Net income changed +104.1% from the comparable as-filed period.
$63.4M→$129.4M2 prior comparisons
Revenue increased 114.7%
Revenue changed +114.7% from the comparable as-filed period.
$223.1M→$479.0M2 prior comparisons
Research & development increased 118.4%
Research & development changed +118.4% from the comparable as-filed period.
$52.4M→$114.5M2 prior comparisons
Cash & equivalents increased 112.6%
Cash & equivalents changed +112.6% from the comparable as-filed period.
$219.6M→$466.9M3 prior comparisons
Operating margin moved 203 bp lower
Operating margin changed -203 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.23%→25.20%2 prior comparisons
Shares outstanding increased 8.6%
Shares outstanding changed +8.6% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
172,995,595→187,951,9187 prior comparisons
Inventory increased 168.3%
Inventory changed +168.3% from the comparable as-filed period.
$116.7M→$313.1M3 prior comparisons
Stock-based compensation increased 148.1%
Stock-based compensation changed +148.1% from the comparable as-filed period.
$35.5M→$88.0M2 prior comparisons
Total assets increased 232.8%
Total assets changed +232.8% from the comparable as-filed period.
$905.2M→$3.0B3 prior comparisons
Trade receivables increased 59.4%
Trade receivables changed +59.4% from the comparable as-filed period.
$181.2M→$288.8M3 prior comparisons
Working capital increased 82.4%
Working capital changed +82.4% from the comparable as-filed period.
$695.2M→$1.3B3 prior comparisons
Current assets increased 82.5%
Current assets changed +82.5% from the comparable as-filed period.
$803.6M→$1.5B3 prior comparisons
Current liabilities increased 82.8%
Current liabilities changed +82.8% from the comparable as-filed period.
$108.4M→$198.2M3 prior comparisons
Gross profit increased 105.5%
Gross profit changed +105.5% from the comparable as-filed period.
$150.4M→$309.1M2 prior comparisons
Selling, general & administrative increased 98.7%
Selling, general & administrative changed +98.7% from the comparable as-filed period.
$37.2M→$73.9M2 prior comparisons
Operating income increased 471.2%
Operating income changed +471.2% from the comparable as-filed period.
$26.2M→$149.6M1 prior comparisons
Operating margin moved 1736 bp higher
Operating margin changed +1736 basis points from the comparable as-filed period.
19.40%→36.76%1 prior comparisons
Net income increased 435.2%
Net income changed +435.2% from the comparable as-filed period.
$29.4M→$157.1M1 prior comparisons
Revenue increased 201.5%
Revenue changed +201.5% from the comparable as-filed period.
$135.0M→$407.0M1 prior comparisons
Gross margin moved 487 bp higher
Gross margin changed +487 basis points from the comparable as-filed period.
63.65%→68.52%1 prior comparisons
Research & development increased 116.4%
Research & development changed +116.4% from the comparable as-filed period.
$36.3M→$78.5M1 prior comparisons
Inventory increased 290.7%
Inventory changed +290.7% from the comparable as-filed period.
$53.2M→$208.0M2 prior comparisons
Cash & equivalents increased 307.9%
Cash & equivalents changed +307.9% from the comparable as-filed period.
$299.2M→$1.2B0 prior comparisons
Gross profit increased 224.5%
Gross profit changed +224.5% from the comparable as-filed period.
$85.9M→$278.9M1 prior comparisons
Inventory / revenue moved 1166 bp higher
Inventory / revenue changed +1166 basis points from the comparable as-filed period.
39.43%→51.09%1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.